← Browse by Condition
Medical Condition
moderate to severe glabellar lines
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 3
NCT07427797 Phase 3
Recruiting
A Study to Assess the Effectiveness and Safety of IPN10200 in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows
Enrollment
300 pts
Location
United States, Canad...
Sponsor
Ipsen
NCT06937944 Phase 3
Recruiting
Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection to Treat Moderate to Severe Glabellar Lines
Enrollment
669 pts
Location
China
Sponsor
JHM BioPharma (Tonghua) Co. , ...